LILRB4 STAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT05518357 · COMPLETED
Trial details
- NCT number
- NCT05518357
- Sponsor
- Hebei Yanda Ludaopei Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-24
- Primary completion
- 2022-11-15
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.